Latest Earnings Analysis
-
ARHS Q1 2025: China Sourcing Shrinks to 13% as Tariff Playbook Drives Margin Defense
July 06, 2025 · ARHS
-
ARGX Q1 2025: Pre-Filled Syringe Drives 50% New Patient Uptake, Expanding Market Reach
July 06, 2025 · ARGX
-
Ardent Health Partners (ARDT) Q1 2025: Admissions Surge 7.6% as Outpatient Expansion and Margin Initiatives Build Leverage
July 06, 2025 · ARDT
-
Arcos Dorados (ARCO) Q1 2025: Digital Channels Reach 60% of Sales Amid Margin Pressure
July 06, 2025 · ARCO
-
ARCC Q2 2025: $2.6B Backlog Anchors Market Share Gains as Direct Lending Outperforms
July 06, 2025 · ARCC
-
ArcBest (ARCB) Q1 2025: Dynamic Quote Volume Up 55% as Core LTL Pipeline Expands
July 06, 2025 · ARCB
-
Aquestive Therapeutics (AQST) Q1 2025: $8.7M Revenue Drop Highlights Anafilm Launch Bet
July 06, 2025 · AQST
-
Algonquin Power (AQN) Q1 2025: Regulated Net Earnings Jump 43% as Strategic Reset Gains Traction
July 06, 2025 · AQN
-
Apogee (APOG) Q4 2025: Tariff Headwinds Cut $0.50 EPS, Forcing Cost and Supply Chain Overhaul
July 06, 2025 · APOG
-
Apellis (APLS) Q1 2025: 4% Injection Growth Masks Channel and Copay Headwinds, Eyes Empaveli Launch
July 06, 2025 · APLS
-
Applied Digital (APLD) Q3 2025: $5B Macquarie Capital Infusion Reshapes Data Center Growth Trajectory
July 06, 2025 · APLD
-
APEI (APEI) Q1 2025: Rasmussen Delivers $5M EBITDA Swing as Enrollment Growth Drives Margin Expansion
July 06, 2025 · APEI
-
APA (APA) Q1 2025: Permian Well Costs Down $800K, Accelerating Capital Efficiency Timeline
July 06, 2025 · APA
-
A.O. Smith (AOS) Q1 2025: Tariff Cost Exposure Hits 6-8% of COGS, Accelerating Mexico Shift
July 06, 2025 · AOS
-
Artivion (AORT) Q1 2025: Stent Graft Revenue Jumps 19% as AMDS and Onyx Recovery Fuel Guidance Raise
July 06, 2025 · AORT
-
Angel Oak Mortgage REIT (AOMR) Q1 2025: Net Interest Income Climbs 18% as Securitization Flexibility Boosts Earnings Power
July 06, 2025 · AOMR
-
ANI Pharmaceuticals (ANIP) Q1 2025: Rare Disease Revenue Jumps 87% as Cortrophin Gel Expands Market Reach
July 06, 2025 · ANIP
-
Anika (ANIK) Q1 2025: Commercial Channel Grows 18% as OEM Pricing Headwinds Cut Margins
July 06, 2025 · ANIK
-
AngioDynamics (ANGO) Q3 2025: MedTech Surges 22% as AlphaVac Adoption Accelerates
July 06, 2025 · ANGO
-
Angi (ANGI) Q1 2025: Network Lead Volume Down 57% as Homeowner Choice Resets Platform Economics
July 06, 2025 · ANGI
-
Andersons (ANDE) Q1 2025: Renewables EBITDA Climbs 9% as Agribusiness Faces Tariff Headwinds
July 06, 2025 · ANDE
-
AutoNation (AN) Q1 2025: Share Count Down 4% as Tariff Uncertainty Drives Capital Discipline
July 06, 2025 · AN
-
Amerant Bancorp (AMTB) Q1 2025: Classified Loans Jump 24% as Risk Controls Tighten
July 06, 2025 · AMTB
-
Amneal (AMRX) Q1 2025: Biosimilars Top $160M as U.S. Manufacturing Drives Margin Expansion
July 06, 2025 · AMRX
-
Ameresco (AMRC) Q1 2025: Project Backlog Jumps 80%, Unlocking $2.6B in Contracted Visibility
July 06, 2025 · AMRC
-
Alpha Metallurgical Resources (AMR) Q1 2025: ABL Facility Expands to $225M as Volumes Cut 1.4M Tons
July 06, 2025 · AMR
-
Amplify Energy (AMPY) Q1 2025: Beta Production Jumps 35% as Capital Shifts to Cash Preservation
July 06, 2025 · AMPY
-
CBRE (CBRE) Q1 2025: Resilient SOP Now 60% of Mix, Buffering Tariff Shock
July 06, 2025 · AMPS
-
Amplitude (AMPL) Q1 2025: Multi-Product Mix Hits 64% of ARR, Driving Enterprise Platform Momentum
July 06, 2025 · AMPL
-
Amylix Pharmaceuticals (AMLX) Q1 2025: Expenses Down 82% as Pipeline Milestones Stack Up
July 06, 2025 · AMLX
-
Amkor Technology (AMKR) Q1 2025: Computing Up 21% as Arizona Expansion Accelerates Advanced Packaging Push
July 06, 2025 · AMKR
-
AMC Networks (AMCX) Q1 2025: Streaming Revenue Jumps 8% as Bundled Distribution Strategy Gains Traction
July 06, 2025 · AMCX
-
AMBAC (AMBC) Q1 2025: BEAT Acquisition Lifts Revenue 27% as MGA Platform Diversifies
July 06, 2025 · AMBC
-
Alvotech (ALVO) Q1 2025: Raises Revenue Guidance to $700M as Biosimilar Launches Accelerate
July 06, 2025 · ALVO
-
Autoliv (ALV) Q1 2025: Operating Margin Jumps 230bps as Tariff Pass-Through Shields Profitability
July 06, 2025 · ALV
-
ALTI Q1 2025: Recurring Revenue Reaches 83% as Germany Entry and Cost Overhaul Reshape Growth Path
July 06, 2025 · ALTI
-
Altimmune (ALT) Q1 2025: $100M Credit Facility Extends Runway as MASH Phase 2b Readout Nears
July 06, 2025 · ALT
-
Alaris Financial (ALRS) Q1 2025: Non-Interest Income Hits 40% of Revenue, Cementing Fee-Based Differentiation
July 06, 2025 · ALRS
-
Alarm.com (ALRM) Q1 2025: Energy Hub Drives 9% SaaS Growth as Commercial Retention Hits 98%
July 06, 2025 · ALRM
-
Allogene (ALLO) Q1 2025: Cash Runway Extended to 2027 as Alpha-3 Trial Consents Double
July 06, 2025 · ALLO
-
Allegion (ALLE) Q1 2025: $80M Tariff Headwind Met with Aggressive Pricing, Margin Expansion Holds
July 06, 2025 · ALLE
-
System1 (SST) Q1 2025: Owned & Operated Product Revenue Jumps 51% as AI-First Pivot Accelerates
July 06, 2025 · ALIT
-
Allegiant (ALGT) Q1 2025: MAX Fleet Drives 35% EBITDA Advantage as Capacity Tightens
July 06, 2025 · ALGT
-
Allegro MicroSystems (ALGM) Q4 2025: Backlog Up 20% as E-Mobility and Data Center Demand Signal Recovery
July 06, 2025 · ALGM
-
Alamo Group (ALG) Q1 2025: Industrial Equipment Margin Expands 120bps as Vegetation Bookings Rebound
July 06, 2025 · ALG
-
Aldeyra (ALDX) Q2 2025: Chamber Trial Delivers 8x Lower Discomfort, Accelerating NDA Path
July 06, 2025 · ALDX
-
Astera Labs (ALAB) Q1 2025: Scorpio Product Revenue to Exceed 10% of Sales, Anchoring Rack-Scale AI Play
July 06, 2025 · ALAB
-
Air Lease (AL) Q1 2025: Insurance Proceeds Lift Book Value to $62, Unlocking Capital Flexibility
July 06, 2025 · AL
-
Akebia (AKBA) Q1 2025: Vafseo Launch Drives $12M Debut, Setting Up Doubling Patient Access with LDO Rollout
July 06, 2025 · AKBA
-
AKA Brands (AKA) Q1 2025: Gross Margin Expands 100bps as Tariff Response Accelerates Supply Shift
July 06, 2025 · AKA